Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Merrion collaborates with Novo Nordisk on GLP-1 receptor agonist development

Jan. 30, 2009

FDA accepts as complete Eurand's response to June 2008 approvable letter for EUR-1008

Jan. 30, 2009

Soliris receives marketing approval in Canada for patients with PNH

Jan. 30, 2009

New cathepsin K inhibitors developed at AstraZeneca

Jan. 30, 2009

Histamine H3 receptor modulators for treating obesity developed at Roche

Jan. 30, 2009

FDA advisory panel to review pegloticase BLA for treatment-failure gout

Jan. 29, 2009

KV receives notice of delayed NDA approval for Gestiva

Jan. 27, 2009

Rexahn completes patient enrollment in phase IIa clinical trial of Zoraxel for ED

Jan. 27, 2009

Novel SSTR5 antagonists with antidiabetic properties developed at Roche

Jan. 27, 2009

DiaKine reports results from preclinical mouse study of lisofylline in type 2 diabetes

Jan. 26, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...